Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2026-04-22 Remuneration Information
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
安杰思关于2026年度董事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the remuneration scheme for the company's directors and senior management for the year 2026. It details the salary structure, performance pay, and long-term incentives for these individuals. It references the 2025 annual report for confirmation of prior year remuneration but does not contain actual financial statements or comprehensive financial data. The document is a formal announcement of the remuneration plan rather than a full remuneration report or proxy statement. Therefore, it fits best under the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2026-04-22 Chinese
安杰思2025年度独立董事述职报告-冯洋
Governance Information Classification · 87% confidence The document is a detailed 2025 annual performance report of an independent director (“独立董事述职报告”) of Hangzhou Anjiese Medical Technology Co., Ltd. It covers board meeting attendance, committee work, oversight of related-party transactions, internal controls and other governance matters. It is not a financial statement or earnings release, nor an announcement of a report. It primarily addresses board governance and director duties, fitting the Governance Information category.
2026-04-22 Chinese
安杰思关于提请股东会授权董事会制定2026年中期分红方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from the board of directors of Hangzhou Anjiesi Medical Technology Co., Ltd. regarding the proposal to authorize the board to formulate the 2026 interim dividend plan. It discusses the conditions for the dividend, the amount, the authorization period, and the related decision-making procedures. The document is relatively short (1239 characters) and does not contain actual financial statements or detailed financial data. It is primarily an announcement about a dividend plan proposal and authorization request to shareholders, not the dividend payment notice itself or a full financial report. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), as it relates to dividend arrangements and shareholder authorization for dividends.
2026-04-22 Chinese
中信证券股份有限公司关于杭州安杰思医学科技股份有限公司2025年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the special audit opinion on the storage and use of raised funds for Hangzhou Anjiesi Medical Technology Co., Ltd. for the fiscal year 2025. It includes specific financial figures about the amount raised, usage during the reporting period, balance at period end, management of the funds, and detailed cash management activities. The document references regulatory approvals and compliance with securities laws and stock exchange rules. It is a comprehensive report focused on the use and management of funds raised through an initial public offering (IPO) and subsequent cash management, which aligns with the characteristics of an Audit Report / Information (AR) rather than a full Annual Report or other categories. The document length is substantial (15,000 characters), and it contains detailed financial data and audit findings, not merely an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2025
2026-04-22 Chinese
天健审〔2026〕8050号-安杰思2025年度年报审计报告
Audit Report / Information Classification · 85% confidence The document is a full standalone audit report issued by Tianjian for Hangzhou Anjiesi Medical Technology Co., Ltd. covering the audit opinion, basis of opinion, key audit matters, audit procedures, management and auditor responsibilities, followed by complete consolidated and parent company financial statements and notes for the year ended December 31, 2025. It is not merely an announcement or publication notice, but the actual audited financial statements with audit opinion. Therefore, it fits the standalone Audit Report / Information category. FY 2025
2026-04-22 Chinese
安杰思关于召开2025年年度股东会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2025 Annual General Meeting (AGM) of Hangzhou Anjiesi Medical Technology Co., Ltd., including the date, voting methods, agenda items, and procedural details. It references the 2025 Annual Report and other reports to be reviewed at the meeting but does not contain the reports themselves. The document is a formal announcement to shareholders about the AGM and related voting procedures, not the actual annual report or financial statements. The document length is 4205 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.